PubMed COVID-19 Clinical Care

No abstract

In addition to proteins, discussed in the Chapter "Advances in Vaccine Adjuvants: Nanomaterials and Small Molecules", there are a wide range of alternatives to small molecule active ingredients. Cells, extracellular vesicles, and nucleic acids in

The author expresses themselves with a poem about their experiences with COVID-19. They talk about how the about the lack of connection and grief during the pandemic. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

The prevalence of depression, anxiety, and post-traumatic stress disorder (PTSD) was examined in 238 pregnant women with (n = 146) and without (n = 92) coronavirus disease 2019 (COVID-19) using the State-Trait Anxiety Inventory (STAI), Edinburgh

Seizure aggravation following coronavirus disease 2019 (COVID-19) vaccines is a major cause behind vaccine hesitancy among persons with epilepsy (PwE), resulting in lower immunization rates. We systematically reviewed seizure-activity-related events

CONCLUSIONS: These findings strongly suggest a major role for both IL-6 trans-signaling and IL-1β signaling in the pathological increase in permeability of the human lung microvasculature and reveal combinatorial strategies that enable the gradual

The authors of the Comments on: Effect of physical activity on long COVID fatigue by Daungsupawong F. and Wiwanitkit V. (2023) have highlighted certain aspects of future research that need to be considered before any conclusions can be drawn

Background: This study examined the correlation of classroom ventilation (air exchanges per hour (ACH)) and exposure to CO (2) ≥ 1,000 ppm with the incidence of SARS-CoV-2 over a 20-month period in a specialized school for students with intellectual

BACKGROUND: During the first pandemic phase of COVID-19, an epidemiological study, named First survey, was conducted on the population of a small rural area in northern Italy. In spring 2020, the results showed how a prolonged lockdown slowed down

[This retracts the article DOI: 10.3389/fpsyt.2022.990678.].